Home/Recalls/CANADA-73862
Health CanadaGeneral Alert

Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabel...

Published: June 21, 2023Recall ID: 73862Category: generalCountry: Canada

Reason for Recall / Hazard

Labelling

Product Description & Identification

Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Affected Products

JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.

Additional Source Details

FieldValue
N I D73862
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/certain-bottles-jamp-venlafaxine-xr-375-mg-capsules-recalled-due-mislabelling-could
IssueLabelling
TitleCertain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose
ProductJAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.
Archived0
CategoryDrugs
Last updated2023-06-21
OrganizationCommunications and Public Affairs Branch
What you should doCheck the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Overview

  • Recalling FirmCommunications and Public Affairs Branch
Official Agency Alert